UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.435

Sortiert nach

THE BARE LYMPHOCYTE SYNDROME AND THE REGULATION OF MHC EXPRESSION

Annual review of immunology, 2001-01, Vol.19 (1), p.331-373

2001

Volltextzugriff (PDF)

Origins of skeletal pain: sensory and sympathetic innervation of the mouse femur

Neuroscience, 2002-01, Vol.113 (1), p.155-166

2002

Volltextzugriff (PDF)

Tumor-induced injury of primary afferent sensory nerve fibers in bone cancer pain

Experimental neurology, 2005-05, Vol.193 (1), p.85-100

2005

Volltextzugriff (PDF)

Bone Cancer Pain: From Model to Mechanism to Therapy

Journal of pain and symptom management, 2005-05, Vol.29 (5), p.32-46

2005

Volltextzugriff (PDF)

Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord

Nature medicine, 2000-05, Vol.6 (5), p.521-528

2000

Volltextzugriff (PDF)

Osteoprotegerin diminishes advanced bone cancer pain

Cancer research (Chicago, Ill.), 2001-05, Vol.61 (10), p.4038-4047

2001

Volltextzugriff (PDF)

Simultaneous reduction in cancer pain, bone destruction, and tumor growth by selective inhibition of cyclooxygenase-2

Cancer research (Chicago, Ill.), 2002-12, Vol.62 (24), p.7343-7349

2002

Volltextzugriff (PDF)

Different tumors in bone each give rise to a distinct pattern of skeletal destruction, bone cancer‐related pain behaviors and neurochemical changes in the central nervous system

International journal of cancer, 2003-05, Vol.104 (5), p.550-558

2003

Volltextzugriff (PDF)

Bone cancer pain: the effects of the bisphosphonate alendronate on pain, skeletal remodeling, tumor growth and tumor necrosis

Pain (Amsterdam), 2004-09, Vol.111 (1), p.169-180

2004

Volltextzugriff (PDF)

Nomenclature for factors of the HLA system, 2010

Tissue antigens, 2010-04, Vol.75 (4), p.291-455

2010

Volltextzugriff (PDF)

Efficacy of systemic morphine suggests a fundamental difference in the mechanisms that generate bone cancer vs. inflammatory pain

Pain (Amsterdam), 2002-10, Vol.99 (3), p.397-406

2002

Volltextzugriff (PDF)

RFX proteins, a novel family of DNA binding proteins conserved in the eukaryotic kingdom

Nucleic acids research, 1996, Vol.24 (5), p.803

1996

Volltextzugriff (PDF)

An update to HLA Nomenclature, 2010

Bone marrow transplantation (Basingstoke), 2010-05, Vol.45 (5), p.846-848

2010

Volltextzugriff (PDF)

A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome)

Genes & development, 1995-05, Vol.9 (9), p.1021-1032

1995

Volltextzugriff (PDF)

Function of Major Histocompatibility Complex Class II Promoters Requires Cooperative Binding between Factors RFX and NF-Y

Proceedings of the National Academy of Sciences - PNAS, 1994-01, Vol.91 (2), p.554-558

1994

Volltextzugriff (PDF)

Developmental extinction of major histocompatibility complex class II gene expression in plasmocytes is mediated by silencing of the transactivator gene CIITA

The Journal of experimental medicine, 1994-10, Vol.180 (4), p.1329-1336

1994

Volltextzugriff (PDF)

MHC Class II-Deficient Combined Immunodeficiency: A Disease of Gene Regulation

Immunological reviews, 1994-04, Vol.138 (1), p.207-221

1994

Volltextzugriff (PDF)

RFX1, a transactivator of hepatitis B virus enhancer I, belongs to a novel family of homodimeric and heterodimeric DNA-binding proteins

Molecular and Cellular Biology, 1994-02, Vol.14 (2), p.1230-1244

1994

Volltextzugriff (PDF)

Social Structure and Personality under Conditions of Radical Social Change: A Comparative Analysis of Poland and Ukraine

American sociological review, 1997-08, Vol.62 (4), p.614-638

1997

Volltextzugriff (PDF)

Efficient repression of endogenous major histocompatibility complex class II expression through dominant negative CIITA mutants isolated by a functional selection strategy

Molecular and Cellular Biology, 1997-08, Vol.17 (8), p.4249-4258

1997

Volltextzugriff (PDF)

A phase 1 open-label, sequential dose-escalation study investigating the safety, tolerability, and pharmacokinetics of intravenous TLC388 administered to patients with advanced solid tumors

Investigational new drugs, 2014-06, Vol.32 (3), p.445-451

2014

Volltextzugriff (PDF)

Planning the Finances of the Health Sector: A Manual for Developing Countries

1983

Volltextzugriff (PDF)

Cooperative binding between factors RFX and X2bp to the X and X2 boxes of MHC class II promoters

The Journal of biological chemistry, 1994-08, Vol.269 (31), p.20020-20025

1994

Volltextzugriff (PDF)

Niveau und Entwicklung der Gesamtkosten für das Niederbringen von Bohrungen in Abhängigkeit von der Endteufe

Januar 1978, 2022, Vol.24, Heft 1, p.18-20

2022

Volltextzugriff (PDF)

Functional complementation of major histocompatibility complex class II regulatory mutants by the purified X-box-binding protein RFX

Molecular and Cellular Biology, 1994-10, Vol.14 (10), p.6839-6847

1994

Volltextzugriff (PDF)

1 – 25 von 1.435

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.126)
Mit Volltextzugriff
(1.169)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.198)
Japanisch
(129)
Deutsch
(122)
Polnisch
(76)
Französisch
(29)
Russisch
(10)
Tschechisch
(6)
Spanisch
(1)
Norwegisch
(1)

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(655)
Humans
(519)
Life Sciences & Biomedicine
(501)
Biological And Medical Sciences
(247)
Animals
(218)
Male
(179)
Female
(176)
Physical Sciences
(127)
Fundamental And Applied Biological Sciences. Psychology
(126)
Medical Sciences
(126)
Immunology
(117)
Mice
(117)
Physics
(107)
Middle Aged
(85)
Adult
(84)
Base Sequence
(74)
Biochemistry & Molecular Biology
(72)
Molecular Sequence Data
(72)
Aged
(65)
Genes, Mhc Class Ii
(64)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

THE BARE LYMPHOCYTE SYNDROME AND THE REGULATION OF MHC EXPRESSION

Origins of skeletal pain: sensory and sympathetic innervation of the mouse femur

Tumor-induced injury of primary afferent sensory nerve fibers in bone cancer pain

Bone Cancer Pain: From Model to Mechanism to Therapy

Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord

Osteoprotegerin diminishes advanced bone cancer pain

Simultaneous reduction in cancer pain, bone destruction, and tumor growth by selective inhibition of cyclooxygenase-2

Different tumors in bone each give rise to a distinct pattern of skeletal destruction, bone cancer‐related pain behaviors and neurochemical changes in the central nervous system

Bone cancer pain: the effects of the bisphosphonate alendronate on pain, skeletal remodeling, tumor growth and tumor necrosis

Nomenclature for factors of the HLA system, 2010

Efficacy of systemic morphine suggests a fundamental difference in the mechanisms that generate bone cancer vs. inflammatory pain

RFX proteins, a novel family of DNA binding proteins conserved in the eukaryotic kingdom

An update to HLA Nomenclature, 2010

A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome)

Function of Major Histocompatibility Complex Class II Promoters Requires Cooperative Binding between Factors RFX and NF-Y

Developmental extinction of major histocompatibility complex class II gene expression in plasmocytes is mediated by silencing of the transactivator gene CIITA

MHC Class II-Deficient Combined Immunodeficiency: A Disease of Gene Regulation

RFX1, a transactivator of hepatitis B virus enhancer I, belongs to a novel family of homodimeric and heterodimeric DNA-binding proteins

Social Structure and Personality under Conditions of Radical Social Change: A Comparative Analysis of Poland and Ukraine

Efficient repression of endogenous major histocompatibility complex class II expression through dominant negative CIITA mutants isolated by a functional selection strategy

A phase 1 open-label, sequential dose-escalation study investigating the safety, tolerability, and pharmacokinetics of intravenous TLC388 administered to patients with advanced solid tumors

Planning the Finances of the Health Sector: A Manual for Developing Countries

Cooperative binding between factors RFX and X2bp to the X and X2 boxes of MHC class II promoters

Niveau und Entwicklung der Gesamtkosten für das Niederbringen von Bohrungen in Abhängigkeit von der Endteufe

Functional complementation of major histocompatibility complex class II regulatory mutants by the purified X-box-binding protein RFX

Suchergebnisse filtern